{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:54:05Z","timestamp":1793224445667,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG066707"],"award-info":[{"award-number":["R01AG066707"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["ALZDISCOVERY- 1051936"],"award-info":[{"award-number":["ALZDISCOVERY- 1051936"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neurot.2026.e00836","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T04:59:32Z","timestamp":1770958772000},"page":"e00836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Network-based prediction and real-world patient data observation identify doxycycline as a repurposable drug in Alzheimer's disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Marina","family":"Bykova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehud","family":"Karavani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Danziger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reina","family":"Tonegawa-Kuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhendong","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Pieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Rosen-Zvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feixiong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.neurot.2026.e00836_bib1","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The Amyloid-\u03b2 pathway in Alzheimer's disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol Psychiatr"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00836_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00836_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"7964","key":"10.1016\/j.neurot.2026.e00836_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-023-06120-6","article-title":"Myelin dysfunction drives amyloid-\u03b2 deposition in models of Alzheimer's disease","volume":"618","author":"Depp","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00836_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/alz.12683","article-title":"The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis","volume":"19","author":"Ashleigh","year":"2023","journal-title":"Alzheimer's Dement"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00836_bib6","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1002\/alz.13792","article-title":"The shift in the fatty acid composition of the circulating lipidome in Alzheimer's disease","volume":"20","author":"Dakterzada","year":"2024","journal-title":"Alzheimer's Dement"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00836_bib7","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/alz.12694","article-title":"Global estimates on the number of persons across the Alzheimer's disease continuum","volume":"19","author":"Gustavsson","year":"2023","journal-title":"Alzheimer's Dement"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00836_bib8","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"2024 Alzheimer's disease facts and figures","volume":"20","year":"2024","journal-title":"Alzheimer's Dement"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00836_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41514-024-00136-6","article-title":"Cost of care for Alzheimer's disease and related dementias in the United States: 2016 to 2060","volume":"10","author":"Nandi","year":"2024","journal-title":"npj Aging"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00836_bib10","article-title":"Alzheimer's disease drug development pipeline: 2024","volume":"10","author":"Cummings","year":"2024","journal-title":"Alzheimer's Dement: Translational Research & Clinical Interventions"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00836_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13195-022-01124-2","article-title":"Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study","volume":"14","author":"McDade","year":"2022","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00836_bib12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00836_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004568","article-title":"Efficacy and safety of passive immunotherapies targeting amyloid beta in Alzheimer's disease: a systematic review and meta-analysis","volume":"22","author":"Tonegawa-Kuji","year":"2025","journal-title":"PLoS Med"},{"issue":"40","key":"10.1016\/j.neurot.2026.e00836_bib14","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2513120122","article-title":"Biliverdin reductase A is a major determinant of protective NRF2 signaling","volume":"122","author":"Vasavda","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00836_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2023.101913","article-title":"A comprehensive review of discovery and development of drugs discovered from 2020-2022","volume":"32","author":"Shareef","year":"2024","journal-title":"Saudi Pharm J"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00836_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.15445","article-title":"Costs of drug development and research and development intensity in the US, 2000-2018","volume":"7","author":"Sertkaya","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.neurot.2026.e00836_bib17","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/s43587-021-00138-z","article-title":"Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's disease","volume":"1","author":"Fang","year":"2021","journal-title":"Nat Aging"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00836_bib18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3233\/JAD-231391","article-title":"Sildenafil as a candidate drug for Alzheimer's disease: real-world patient data observation and mechanistic observations from patient-induced pluripotent stem cell-derived neurons","volume":"98","author":"Gohel","year":"2024","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"10.1016\/j.neurot.2026.e00836_bib19","article-title":"Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation","volume":"3","author":"Lal","year":"2022","journal-title":"Cell Rep Med"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00836_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111717","article-title":"Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer's disease","volume":"41","author":"Xu","year":"2022","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00836_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14373","article-title":"Single-microglia transcriptomic transition network-based prediction and real-world patient data validation identifies ketorolac as a repurposable drug for Alzheimer's disease","volume":"21","author":"Xu","year":"2025","journal-title":"Alzheimer's Dement"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00836_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41531-025-00870-y","article-title":"A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson's disease","volume":"11","author":"Dou","year":"2025","journal-title":"npj Parkinson's Dis"},{"issue":"10","key":"10.1016\/j.neurot.2026.e00836_bib23","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.cell.2021.03.032","article-title":"Reducing acetylated tau is neuroprotective in brain injury","volume":"184","author":"Shin","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00836_bib24","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1038\/s41467-018-05116-5","article-title":"Network-based approach to prediction and population-based validation of in silico drug repurposing","volume":"9","author":"Cheng","year":"2018","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00836_bib25","article-title":"Type 3 diabetes mellitus: a link between Alzheimer's disease and type 2 diabetes mellitus","volume":"12","author":"Nisar","year":"2020","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00836_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11065-017-9359-z","article-title":"The effect of non-stroke cardiovascular disease states on risk for cognitive decline and dementia: a systematic and meta-analytic review","volume":"28","author":"Stefanidis","year":"2018","journal-title":"Neuropsychol Rev"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00836_bib27","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3233\/JAD-230418","article-title":"Diet's role in modifying risk of Alzheimer's disease: history and present understanding","volume":"96","author":"Grant","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurot.2026.e00836_bib28","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3233\/JAD-220159","article-title":"Traumatic brain injury and risk of alzheimer's disease and related dementias in the population","volume":"88","author":"Mielke","year":"2022","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00836_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11041154","article-title":"Increased risk of aging-related neurodegenerative disease after traumatic brain injury","volume":"11","author":"Barker","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.neurot.2026.e00836_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.84","article-title":"Traumatic brain injuries","volume":"2","author":"Blennow","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"46","key":"10.1016\/j.neurot.2026.e00836_bib31","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.15585\/mmwr.mm6846a2","article-title":"Traumatic brain injury-related deaths by race\/ethnicity, sex, intent, and mechanism of injury - united States, 2000-2017","volume":"68","author":"Daugherty","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00836_bib32","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0220-16.2016","article-title":"Acute axonal degeneration drives development of cognitive, motor, and visual deficits after blast-mediated traumatic brain injury in mice","volume":"3","author":"Yin","year":"2016","journal-title":"eNeuro"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00836_bib33","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1212\/WNL.0000000000002413","article-title":"Amyloid pathology and axonal injury after brain trauma","volume":"86","author":"Scott","year":"2016","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00836_bib34","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41582-024-00973-9","article-title":"From spreading depolarization to blood\u2013brain barrier dysfunction: navigating traumatic brain injury for novel diagnosis and therapy","volume":"20","author":"van Hameren","year":"2024","journal-title":"Nat Rev Neurol"},{"issue":"44","key":"10.1016\/j.neurot.2026.e00836_bib35","doi-asserted-by":"crossref","first-page":"27667","DOI":"10.1073\/pnas.2010430117","article-title":"P7C3-A20 treatment one year after TBI in mice repairs the blood-brain barrier, arrests chronic neurodegeneration, and restores cognition","volume":"117","author":"V\u00e1zquez-Rosa","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.neurot.2026.e00836_bib36","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41419-023-05980-0","article-title":"Mitochondria dysregulation contributes to secondary neurodegeneration progression post-contusion injury in human 3D in vitro triculture brain tissue model","volume":"14","author":"Liaudanskaya","year":"2023","journal-title":"Cell Death Dis"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00836_bib37","article-title":"Acutely blocking excessive mitochondrial fission prevents chronic neurodegeneration after traumatic brain injury","volume":"5","author":"Sridharan","year":"2024","journal-title":"Cell Rep Med"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00836_bib38","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.tins.2023.08.008","article-title":"Microglia moonlighting after traumatic brain injury: aging and interferons influence chronic microglia reactivity","volume":"46","author":"Wangler","year":"2023","journal-title":"Trends Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00836_bib39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/02699052.2017.1380228","article-title":"Repeated mild traumatic brain injury produces neuroinflammation, anxiety-like behaviour and impaired spatial memory in mice","volume":"32","author":"Broussard","year":"2018","journal-title":"Brain Inj"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00836_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13024-024-00733-9","article-title":"Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury","volume":"19","author":"Parra Bravo","year":"2024","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.neurot.2026.e00836_bib41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fneur.2020.00348","article-title":"Inflammatory cytokines associate with neuroimaging after acute mild traumatic brain injury","volume":"11","author":"Edwards","year":"2020","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00836_bib42","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0385-17.2018","article-title":"Combined blockade of Interleukin-1\u03b1 and -1\u03b2 signaling protects mice from cognitive dysfunction after traumatic brain injury","volume":"5","author":"Newell","year":"2018","journal-title":"eNeuro"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00836_bib43","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/brain\/awx354","article-title":"Spatial patterns of progressive brain volume loss after moderate-severe traumatic brain injury","volume":"141","author":"Cole","year":"2018","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00836_bib44","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s40478-022-01413-9","article-title":"Neuropathology in chronic traumatic encephalopathy: a systematic review of comparative post-mortem histology literature","volume":"10","author":"Murray","year":"2022","journal-title":"Acta Neuropathol Commun"},{"issue":"10","key":"10.1016\/j.neurot.2026.e00836_bib45","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1001\/jamaneurol.2023.2907","article-title":"Neuropathologic and clinical findings in young contact sport athletes exposed to repetitive head impacts","volume":"80","author":"McKee","year":"2023","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00836_bib46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000520966","article-title":"Traumatic brain injury and risk of dementia and Alzheimer's disease: a systematic review and meta-analysis","volume":"56","author":"Gu","year":"2022","journal-title":"Neuroepidemiology"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00836_bib47","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3233\/JAD-220069","article-title":"Mild traumatic brain injuries and future risk of developing Alzheimer's disease: systematic review and meta-analysis","volume":"87","author":"Graham","year":"2022","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00836_bib48","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/med.21709","article-title":"Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing","volume":"40","author":"Fang","year":"2020","journal-title":"Med Res Rev"},{"issue":"D1","key":"10.1016\/j.neurot.2026.e00836_bib49","doi-asserted-by":"crossref","first-page":"D1302","DOI":"10.1093\/nar\/gkaa1027","article-title":"Open targets platform: supporting systematic drug-target identification and prioritisation","volume":"49","author":"Ochoa","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00836_bib50","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5195\/jmla.2018.253","article-title":"Malacards: the human disease database","volume":"106","author":"Espe","year":"2018","journal-title":"J Med Libr Assoc"},{"issue":"D1","key":"10.1016\/j.neurot.2026.e00836_bib51","first-page":"D845","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pi\u00f1ero","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"10.1016\/j.neurot.2026.e00836_bib52","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","article-title":"The human gene mutation database (HGMD(\u00ae)): optimizing its use in a clinical diagnostic or research setting","volume":"139","author":"Stenson","year":"2020","journal-title":"Hum Genet"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00836_bib53","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer's disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00836_bib54","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","article-title":"A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease","volume":"53","author":"Wightman","year":"2021","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00836_bib55","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1038\/s41467-019-10744-6","article-title":"A genome-wide positioning systems network algorithm for in silico drug repurposing","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat Commun"},{"issue":"18","key":"10.1016\/j.neurot.2026.e00836_bib56","doi-asserted-by":"crossref","first-page":"10170","DOI":"10.1021\/acs.jmedchem.0c00415","article-title":"Essential medicinal chemistry of essential medicines","volume":"63","author":"Serafini","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.neurot.2026.e00836_bib57","series-title":"Merative MarketScan research databases","year":"2022"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00836_bib58","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/jama.2020.9151","article-title":"Immortal time bias in observational studies","volume":"325","author":"Yadav","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.neurot.2026.e00836_bib59","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jclinepi.2017.11.021","article-title":"Electronic medical records can be used to emulate target trials of sustained treatment strategies","volume":"96","author":"Danaei","year":"2018","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.neurot.2026.e00836_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2024.111457","article-title":"Intention to treat and per protocol analyses: differences and similarities","volume":"173","author":"Molero-Calafell","year":"2024","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00836_bib61","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/nep.13709","article-title":"Intention to treat and per protocol analysis in clinical trials","volume":"25","author":"Tripepi","year":"2020","journal-title":"Nephrology (Carlton)"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00836_bib62","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chron Dis"},{"key":"10.1016\/j.neurot.2026.e00836_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.631584","article-title":"Emulated clinical trials from longitudinal real-world data efficiently identify candidates for neurological disease modification: examples from Parkinson's disease","volume":"12","author":"Laifenfeld","year":"2021","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00836_bib64","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/pds.5338","article-title":"Core concepts in pharmacoepidemiology: violations of the positivity assumption in the causal analysis of observational data: consequences and statistical approaches","volume":"30","author":"Zhu","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00836_bib65","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1213\/ANE.0000000000003653","article-title":"Survival analysis and interpretation of time-to-event data: the tortoise and the hare","volume":"127","author":"Schober","year":"2018","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00836_bib66","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/biomet\/asn055","article-title":"Dealing with limited overlap in estimation of average treatment effects","volume":"96","author":"Crump","year":"2009","journal-title":"Biometrika"},{"issue":"25","key":"10.1016\/j.neurot.2026.e00836_bib67","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00836_bib68","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.neurot.2026.e00836_bib69","series-title":"An evaluation toolkit to guide model selection and cohort definition in causal inference","author":"Shimoni","year":"2019"},{"issue":"12","key":"10.1016\/j.neurot.2026.e00836_bib70","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/bloodadvances.2019032268","article-title":"External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation","volume":"3","author":"Shouval","year":"2019","journal-title":"Blood Adv"},{"issue":"30","key":"10.1016\/j.neurot.2026.e00836_bib71","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1002\/sim.7084","article-title":"Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis","volume":"35","author":"Austin","year":"2016","journal-title":"Stat Med"},{"key":"10.1016\/j.neurot.2026.e00836_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.csbj.2016.10.003","article-title":"Determining the molecular pathways underlying the protective effect of non-steroidal anti-inflammatory drugs for Alzheimer's disease: a bioinformatics approach","volume":"15","author":"Nevado-Holgado","year":"2017","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00836_bib73","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1038\/s41598-022-09394-4","article-title":"Doxycycline prevents blood\u2013brain barrier dysfunction and microvascular hyperpermeability after traumatic brain injury","volume":"12","author":"Robinson","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2026.e00836_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111471","article-title":"Intranasal irbesartan reverts cognitive decline and activates the PI3K\/AKT pathway in an LPS-induced neuroinflammation mice model","volume":"128","author":"Gouveia","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.neurot.2026.e00836_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107834","article-title":"Irbesartan suppresses lipopolysaccharide (LPS)-induced blood\u2013brain barrier (BBB) dysfunction by inhibiting the activation of MLCK\/MLC","volume":"98","author":"Yang","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00836_bib76","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.neurot.2026.e00836_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.108999","article-title":"Impact of chronic doxycycline treatment in the APP\/PS1 mouse model of Alzheimer's disease","volume":"209","author":"Gomez-Murcia","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurot.2026.e00836_bib78","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neurobiolaging.2018.06.002","article-title":"Doxycycline counteracts neuroinflammation restoring memory in Alzheimer's disease mouse models","volume":"70","author":"Balducci","year":"2018","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurot.2026.e00836_bib79","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3389\/fphar.2019.00738","article-title":"Doxycycline for Alzheimer's disease: fighting \u03b2-Amyloid oligomers and neuroinflammation","volume":"10","author":"Balducci","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.neurot.2026.e00836_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2024.08.006","article-title":"Forget me not: the effect of doxycycline on human declarative memory","volume":"89","author":"Wehrli","year":"2024","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00836_bib81","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/02699052.2019.1566968","article-title":"Safety and feasibility of minocycline in treatment of acute traumatic brain injury","volume":"33","author":"Meythaler","year":"2019","journal-title":"Brain Inj"},{"key":"10.1016\/j.neurot.2026.e00836_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106237","article-title":"The potential use of tetracyclines in neurodegenerative diseases and the role of nano-based drug delivery systems","volume":"175","author":"Rahmani","year":"2022","journal-title":"Eur J Pharmaceut Sci"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00836_bib83","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1007\/s13311-023-01426-9","article-title":"Treating traumatic brain injury with minocycline","volume":"20","author":"Bergold","year":"2023","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00836_bib84","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0243-22.2023","article-title":"Effect of the matrix metalloproteinase inhibitor doxycycline on human trace fear memory","volume":"10","author":"Wehrli","year":"2023","journal-title":"eNeuro"},{"issue":"18","key":"10.1016\/j.neurot.2026.e00836_bib85","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1523\/JNEUROSCI.2751-17.2018","article-title":"Matrix metalloproteinase-mediated blood-brain barrier dysfunction in epilepsy","volume":"38","author":"Rempe","year":"2018","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.neurot.2026.e00836_bib86","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00702-018-1913-1","article-title":"Tetracycline repurposing in neurodegeneration: focus on Parkinson's disease","volume":"125","author":"Bortolanza","year":"2018","journal-title":"J Neural Transm"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00836_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12030575","article-title":"Rescue of dopamine neurons from iron-dependent ferroptosis by doxycycline and demeclocycline and their non-antibiotic derivatives","volume":"12","author":"Tourville","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.neurot.2026.e00836_bib88","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2017.03.010","article-title":"Minocycline reduces inflammatory parameters in the brain structures and serum and reverses memory impairment caused by the administration of amyloid \u03b2 (1-42) in mice","volume":"77","author":"Garcez","year":"2017","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatr"},{"issue":"null","key":"10.1016\/j.neurot.2026.e00836_bib89","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2147\/CIA.S46536","article-title":"Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder","volume":"8","author":"Cai","year":"2013","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.neurot.2026.e00836_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2020.104601","article-title":"Effects of 9-t-butyl doxycycline on the innate immune response to CNS ischemia-reperfusion injury","volume":"118","author":"Mai","year":"2021","journal-title":"Exp Mol Pathol"},{"issue":"17","key":"10.1016\/j.neurot.2026.e00836_bib91","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151540","article-title":"Tetracycline-induced mitohormesis mediates disease tolerance against influenza","volume":"132","author":"Mottis","year":"2022","journal-title":"J Clin Investig"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00836_bib92","doi-asserted-by":"crossref","first-page":"83","DOI":"10.14283\/jpad.2022.81","article-title":"Socioeconomic status and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 39 prospective studies","volume":"10","author":"Wang","year":"2023","journal-title":"J Prevention Alzheimer's Disease"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00836_bib93","first-page":"181","article-title":"Duration of antibiotic therapy for common infections","volume":"6","author":"Grant","year":"2021","journal-title":"J Assoc Med Microbiol Infect Dis Can"},{"issue":"49","key":"10.1016\/j.neurot.2026.e00836_bib94","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2411919121","article-title":"Global trends in antibiotic consumption during 2016-2023 and future projections through 2030","volume":"121","author":"Klein","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurot.2026.e00836_bib95","article-title":"Antimicrobial resistance with a focus on antibacterial, antifungal, antimalarial, and antiviral drugs resistance, its threat, global priority pathogens, prevention, and control strategies: a review","volume":"12","author":"Belay","year":"2025","journal-title":"Ther Adv Infect Dis"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926000061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926000061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T04:52:39Z","timestamp":1776142359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926000061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1878747926000061"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00836","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Network-based prediction and real-world patient data observation identify doxycycline as a repurposable drug in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00836"}}